Skip to content

Markets2026-11-06

Hyperliquid Strategies seeks US futures registration for HIP-3 markets

Signal21 Editorial Desk

A regulated US derivatives market connected to permissioned perpetual futures infrastructure on Hyperliquid.

An application, not a US launch

Hyperliquid Strategies disclosed on November 5 that a subsidiary has applied to become a futures commission merchant, or FCM. If approved, the firm says the subsidiary would carry US customer accounts for permissioned perpetual futures markets deployed on Hyperliquid under the proposed HIP-3* framework.

The disclosure is primary-source evidence: it appears in the company's quarterly results furnished with the Securities and Exchange Commission. It does not mean that Hyperliquid perpetual futures are now available to US customers.

Hyperliquid Strategies explicitly says there is no assurance about the timing or outcome of either the FCM application or regulatory approval for the permissioned HIP-3* markets. It has not announced a launch date, a list of contracts or customer-eligibility terms.

What an FCM would do

An FCM is the regulated intermediary that can solicit or accept futures orders and hold customer money or other assets supporting those positions. The CFTC says FCMs must register and become members of the National Futures Association, subject to capital, customer-funds, disclosure, reporting and other requirements.

That makes the application more than a branding exercise. Hyperliquid Strategies is seeking a role in the regulated account and customer-protection layer needed to bring a version of onchain perpetual markets to US users.

It would not, by itself, authorize every existing Hyperliquid market for US trading. The company's release describes a narrower structure: independent operators would run permissioned markets using Hyperliquid as the underlying infrastructure, while the proposed FCM would carry eligible US accounts.

HIP-3* remains part of the regulatory dependency

Hyperliquid already uses HIP-3 to let third-party deployers create perpetual markets. The additional HIP-3* functionality described by Hyperliquid Strategies would let deployers restrict participation and operate permissioned markets.

The practical distinction matters. A registered FCM is one component of a regulated derivatives stack, not the entire stack. The market operator, contracts, clearing arrangements, custody model and customer-access rules must also fit the applicable CFTC and NFA framework.

That is why the company's caveat covers two separate outcomes: approval of the FCM application and approval of the permissioned markets themselves.

Why this is material

Hyperliquid is best known for perpetual futures, a product category that US regulators and domestic venues are now trying to bring into regulated markets. The CFTC recently cleared a pathway for equity perpetual futures on qualifying US exchanges, although those approvals are already being challenged in court.

The Hyperliquid Strategies application tests a different question: whether a listed HYPE treasury company can build a regulated customer-account gateway to permissioned markets running on Hyperliquid's onchain infrastructure.

Management is financially aligned with that outcome. Hyperliquid Strategies reported holding about 38.5 million HYPE at September 30 and said it had raised $911 million in equity during the quarter, using $785 million to buy another 9.1 million HYPE. Its $620.6 million quarterly net income was driven mainly by $803 million of unrealized gains on those tokens, not by an operating FCM business.

The precise conclusion is: Hyperliquid Strategies has started a formal registration process for a subsidiary that it hopes will carry US accounts for permissioned HIP-3 markets. The filing creates a credible regulatory pathway, but it is not an approval, and no US perpetual-futures launch has been authorized or scheduled.*

This is a developing story. Signal21 will update the article if regulators act on the application or a permissioned market files launch terms.

This publication is market analysis, not a recommendation to buy or sell.

All Markets reads